Published in Invasion Metastasis on January 01, 1995
Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis (2004) 1.00
Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma. World J Gastroenterol (2000) 0.91
Calcium, inorganic phosphates, alkaline and acid phosphatase activities in breast cancer patients in Calabar, Nigeria. Afr Health Sci (2010) 0.78
Effect of vitamin E and human placenta cysteine peptidase inhibitor on expression of cathepsins B and L in implanted hepatoma Morris 5123 tumor model in Wistar rats. World J Gastroenterol (2005) 0.75
Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol (1984) 2.33
Effect of microtubular or translational inhibitors on general cell protein degradation. Evidence for a dual catabolic pathway. Biochem J (1977) 1.93
Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis (1993) 1.80
Cancer cachexia: from experimental models to patient management. Curr Opin Clin Nutr Metab Care (2000) 1.54
Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest (1993) 1.53
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer (2000) 1.31
Studies on the structure-bound sedimentabolity of some rat liver lysosome hydrolases. Biochem J (1971) 1.23
Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun (1999) 1.23
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29. J Biol Chem (1995) 1.14
Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J (1987) 1.12
Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp Cell Res (1995) 1.12
Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest (2008) 1.11
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest (1995) 1.09
Inhibition of basal protein degradation in rat embryo fibroblasts by cycloheximide: correlation with activities of lysosomal proteases. J Cell Physiol (1978) 1.07
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer (2001) 1.03
Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer (1993) 1.02
Structural equivalents of latency for lysosome hydrolases. Biochem J (1975) 1.02
Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta (2001) 1.02
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. Curr Cancer Drug Targets (2009) 1.01
Control of cell protein degradation. Changes in activities of lysosomal proteases. Biochim Biophys Acta (1977) 1.01
Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys (1993) 1.01
Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regul Integr Comp Physiol (2001) 0.99
Altered pattern of lipid metabolism in patients with lung cancer. Oncology (1992) 0.98
Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody. Cell Death Differ (2003) 0.96
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. Cytokine (2002) 0.92
Cell protein degradation in cultured rat embryo fibroblasts. Suppression by vinblastine of the enhanced proteolysis by serum-deficient media. Biochim Biophys Acta (1976) 0.92
Differential segregation of human and hamster cathepsin D in transfected baby-hamster kidney cells. Biochem J (1991) 0.89
Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem J (1994) 0.88
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem Biophys Res Commun (1996) 0.87
Changes induced by fasting and cycloheximide in the vacuolar apparatus of rat hepatocytes. A morphometric investigation. Boll Soc Ital Biol Sper (1979) 0.87
The lysosomal protease cathepsin D is efficiently sorted to and secreted from regulated secretory compartments in the rat basophilic/mast cell line RBL. J Cell Sci (2000) 0.87
Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. Int J Oncol (2005) 0.87
Control of cell protein catabolism in rat liver. Effects of starvation and administration of cycloheximide. Biochem J (1982) 0.87
Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. Free Radic Biol Med (1996) 0.86
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci (Lond) (1994) 0.86
Acute hemorrhagic pancreatic necrosis in mice: the activity of lysosomal enzymes in the pancreas and the liver. Am J Pathol (1980) 0.86
Differentiation-dependent autophagy controls the fate of newly synthesized N-linked glycoproteins in the colon adenocarcinoma HT-29 cell line. Biochem J (1995) 0.85
On the structure-linked sedimentability of rat liver beta-N-acetylglucosaminidase. Biochim Biophys Acta (1971) 0.84
Biochemical and structural changes of rat liver lysosomes by ethionine. Exp Mol Pathol (1975) 0.84
Expression of protein kinase C beta1 confers resistance to TNFalpha- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells. Int J Cancer (2001) 0.84
Lysosomal involvement in liver cell vacuolation by hypoxia. Br J Exp Pathol (1969) 0.84
Impaired macrophage phagocytosis of apoptotic neutrophils in patients with human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol (2002) 0.83
Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. Cell Tissue Res (1997) 0.83
Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D. J Cell Biochem (1999) 0.83
Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies. Clin Sci (Lond) (1995) 0.83
Regulation of protein turnover versus growth state: ascites hepatoma as a model for studies both in the animal and in vitro. Arch Biochem Biophys (1987) 0.83
Tissue protein turnover during liver carcinogenesis. Carcinogenesis (1993) 0.83
Role of mitogen-induced calcium influx in the control of the cell cycle in Balb-c 3T3 fibroblasts. Cell Calcium (1995) 0.82
Cloning and expression of two ornithine decarboxylase forms from HMOA cells. Biochem J (1995) 0.82
Candida albicans and HIV-1 Infection. Cell Biochem Funct (2000) 0.82
Altered intracellular processing and enhanced secretion of procathepsin D in a highly deviated rat hepatoma. Int J Cancer (1995) 0.81
Expression and posttranslational fate of cathepsin D in HT-29 tumor cells depend on their enterocytic differentiation state. Cell Growth Differ (1997) 0.81
Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells. Apoptosis (2005) 0.81
Purification and properties of cathepsin D from rat Yoshida ascites hepatoma AH-130. Biol Chem Hoppe Seyler (1988) 0.81
Apoptosis of L929 cells by etoposide: a quantitative and kinetic approach. Exp Cell Res (1996) 0.81
The direct effect of carbon tetrachloride on subcellular particles. Lab Invest (1966) 0.81
Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal. Int J Cancer (1997) 0.81
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression. Curr Med Chem (2010) 0.80
Stimulation of rat liver beta-galactosidase activity by ions. Biochem J (1975) 0.80
Italian multicenter study of reversible cerebral ischemic attacks. Part 5. Risk factors and cerebral atherosclerosis. Atherosclerosis (1987) 0.80
Suppression of the 'uncovering' of mannose-6-phosphate residues in lysosomal enzymes in the presence of NH4Cl. Eur J Biochem (1990) 0.80
Regulation of protein turnover versus growth state. Studies on the mechanism(s) of initiation of acidic vacuolar proteolysis in cells of stationary ascites hepatoma. Biochem J (1988) 0.80
Potassium and calcium currents activated by foetal calf serum in Balb-c 3T3 fibroblasts. Biochim Biophys Acta (1992) 0.80
Two currents activated by epidermal growth factor in EGFR-T17 fibroblasts. Biochim Biophys Acta (1992) 0.80
Sustained calcium influx activated by basic fibroblast growth factor in Balb-c 3T3 fibroblasts. J Physiol (1995) 0.80
Decreased expression of the high-mobility group protein T160 by antisense RNA impairs the growth of mouse fibroblasts. Biochimie (1997) 0.80
Lysosomal hydrolase activities in the developing rat liver. Boll Soc Ital Biol Sper (1980) 0.79
Further experiments on the action of CCl-4 on lysosomes in vitro. Enzymologia (1965) 0.79
Comparative studies on protein turnover regulations in tumor cells and host tissues: development and analysis of an experimental model. Toxicol Pathol (1986) 0.79
Protein turnover states of tumour cells and host tissues in an experimental model. Biomed Biochim Acta (1986) 0.79
Aliphatic aldehydes inhibit the proliferative response of human peripheral blood lymphocytes to phytohemagglutinin and alloantigens. Chem Biol Interact (1987) 0.79
Control of protein degradation and growth phase in normal and neoplastic cells. Toxicol Pathol (1984) 0.79